Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver
Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
Oxidative stress in non-alcoholic fatty liver disease. An updated mini review
AP Delli Bovi, F Marciano, C Mandato, MA Siano… - Frontiers in …, 2021 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
[HTML][HTML] Oxidative stress in non-alcoholic fatty liver disease. An updated mini review
APD Bovi, F Marciano, C Mandato, MA Siano… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease
Recent studies have demonstrated that obstructive sleep apnea (OSA) is associated with the
development and evolution of nonalcoholic fatty liver disease (NAFLD), independent of …
development and evolution of nonalcoholic fatty liver disease (NAFLD), independent of …
[HTML][HTML] Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway
J Chen, J Chen, H Fu, Y Li, L Wang… - American Journal of …, 2019 - journals.physiology.org
This study aimed to investigate whether hypoxia can affect nonalcoholic fatty liver disease
(NAFLD) progression and the associated mechanisms, specifically regarding the hypoxia …
(NAFLD) progression and the associated mechanisms, specifically regarding the hypoxia …
Obstructive sleep apnea syndrome and metabolic diseases
M Li, X Li, Y Lu - Endocrinology, 2018 - academic.oup.com
With the rapid changes in lifestyle in modern society, including the high nutritional intake
and reduced physical activity, the incidence of metabolic diseases has been increasing year …
and reduced physical activity, the incidence of metabolic diseases has been increasing year …
Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications
E Belaidi, J Morand, E Gras, JL Pépin… - Pharmacology & …, 2016 - Elsevier
Obstructive sleep apnea (OSA) is now recognized as an independent and important risk
factor for cardiovascular diseases such as hypertension, coronary heart disease, heart …
factor for cardiovascular diseases such as hypertension, coronary heart disease, heart …
[HTML][HTML] Association between non-alcoholic fatty liver disease and obstructive sleep apnea
I Umbro, V Fabiani, M Fabiani, F Angelico… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is an emerging liver disease and
currently the most common cause of incidental abnormal liver tests. The pathogenesis of …
currently the most common cause of incidental abnormal liver tests. The pathogenesis of …
Obstructive sleep apnea and the liver
Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of liver disorders, including
the initial stage of simple fat accumulation (hepatic steatosis); followed by inflammatory …
the initial stage of simple fat accumulation (hepatic steatosis); followed by inflammatory …
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
Increasing evidence suggests that obstructive sleep apnea (OSA) is a metabolic syndrome-
related disease; however, the association between nonalcoholic fatty liver disease (NAFLD) …
related disease; however, the association between nonalcoholic fatty liver disease (NAFLD) …